285 Further exploratory analysis revealed that, after 65 weeks of treatment, patients in the cardiomyopathy subgroup experienced improvements in LVEF and left ventricular end-diastolic volume
306 (5), R352R362 (2014)
The FDA nod, which the companies announced on Friday, is specifically for the reduction of risk of sustained decline in estimated glomerular filtration rate (eGFR), end-stage kidney disease and cardiovascular death and hospitalization in adults with CKD at risk of progression
Peptide serums sound exciting to beginners because they carry a premium skincare image, but from a formulation and commercialization standpoint, they can feel intimidating
The body's compensatory response to reduced circulating volume includes an increase in heart rate to maintain adequate cardiac output and blood pressure
Semaglutide (marketed under brand names like Wegovy and Ozempic) and Tirzepatide (Mounjaro and Zepbound) are GLP-1 receptor agonists that help regulate appetite, insulin, and metabolism